alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 83, Number 111 (Friday, June 8, 2018)]
[Notices]
[Page 26714]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12541]


=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION


Sunshine Act Meetings

TIME AND DATE: Notice is hereby given, pursuant to the provisions of 
the Government in Sunshine Act, Public Law 94-409, that the Securities 
and Exchange Commission Investor Advisory Committee will hold a meeting 
in Atlanta, GA on Thursday, June 14, 2018 at 8:30 a.m. (ET).

PLACE: The meeting will be held in the Knowles Conference Center at 
Georgia State University College of Law, 85 Park Place Northeast, 
Atlanta, GA 30303.

STATUS: This meeting will begin at 8:30 a.m. (ET) and will be open to 
the public. Seating will be on a first-come, first-served basis. Doors 
will open at 8:00 a.m. The meeting will be webcast on the Commission's 
website at www.sec.gov.

MATTERS TO BE CONSIDERED: On May 23, 2018, the Commission issued notice 
of the Committee meeting (Release No. 33-10499) indicating that the 
meeting is open to the public (except during that portion of the 
meeting reserved for an administrative work session during lunch), and 
inviting the public to submit written comments to the Committee. This 
Sunshine Act notice is being issued because a quorum of the Commission 
may attend the meeting.
    The agenda for the meeting includes: Remarks from Commissioners; a 
discussion of the Commission's proposed Regulation Best Interest and 
the proposed restriction on the use of certain names or titles; a 
discussion regarding the Commission's proposed Form CRS Relationship 
Summary, including effective disclosure and design; a discussion 
regarding disclosure enhancements for municipal and corporate bonds 
(which may include a recommendation of the Market Structure 
Subcommittee); subcommittee reports; and a nonpublic administrative 
work session.

CONTACT PERSON FOR MORE INFORMATION: For further information and to 
ascertain what, if any, matters have been added, deleted or postponed; 
please contact Brent J. Fields from the Office of the Secretary at 
(202) 551-5400.

    Dated: June 6, 2018.
Brent J. Fields,
Secretary.
[FR Doc. 2018-12541 Filed 6-6-18; 4:15 pm]
 BILLING CODE 8011-01-P
#### Willie Selton BONNER, Appellant, v. The STATE of Florida, Appellee.

No. 76-1117.

District Court of Appeal of Florida, Third District.

Sept. 20, 1977.

Bennett H. Brummer, Public Defender, and Karen M. Gottlieb, Asst. Public Defender, for appellant.

Robert L. Shevin, Atty. Gen., and Arthur Joel Berger, Asst. Atty. Gen., for appellee.

Before BARKDULL, HAVERFIELD and NATHAN, JJ.

PER CURIAM.

Willie Selton Bonner appeals his sentence of three years imprisonment upon his convictions for two separate offenses, breaking and entering and possession of burglary tools.

We remand the instant ease to the trial court for resentencing in accordance with our Supreme Court’s recent decision in *Dorfman v. State*(Fla.Sup.Ct. Case No. 50,026, opinion filed July 28, 1977), wherein it was held that the imposition of general sentences as in the instant case are no longer proper.

So ordered.
Electronically Filed Intermediate Court of Appeals CAAP-14-0000815 15-SEP-2014 10:21 AM
FTC Form 232 (rev 7/11)

FEDERAL TRADE COMMISSION

WASHINGTON, DC 20580

CASE NAME FILE/DOCKET NUMBER

Pursuant to Section 4.1 of the Commission’s Rules of Practice, I (we) am (are) entering in the above 

proceeding the appearance of

□ counsel supporting the complaint (Complete Items 1, 3, 4, and 5 below)

□ counsel or representative for the respondent (Complete Items 1, 2, 4, and 5 below)

□ counsel or representative for a third party (Complete Items 1, 2, 4, and 5 below)

1. COUNSEL OR REPRESENTATIVE 2. RESPONDENT(S) OR THIRD PARTY(IES)

Include the name, address, email address, and telephone 

number of each counsel or representative entering an 

appearance in the above proceeding,

Include the address and telephone numbers of all persons, 

partnerships, corporations, or associations on whose behalf 

this Notice of Appearance is being filed.

3. ASSOCIATE/ASSISTANT DIRECTOR

4. SIGNATURE OF SENIOR COUNSEL 5. DATE SIGNED

Return this form to: Federal Trade Commission

Room H-113

600 Pennsylvania Avenue, N.W.

Washington, D.C. 20580

NOTICE OF APPEARANCE

McWANE, INC., et.al.

Richard Gill (Attorney)

Copeland, Franco, Screws & Gill, P.A.

P. O. Box 347

Montgomery, AL 36101

Phone: 334-834-1180

Fax Number: 334-834-3172

(Richard Gill) D09351 8/31/2012

Tommy Brakefield

c/o Matthew A. WhiteBallard Spahr LLP

Ballard Spahr LLP

1735 Market Street, 51st Floor

Philadelphia, PA 19103

Phone: 215-665-8500

08 31 2012
Fourth Court of Appeals

San Antonio, Texas

November 19, 2014

No. 04-14-00531-CV

IN THE INT OF RVM, NM, MBRC, RABC AND SRRC,

From the 225th Judicial District Court, Bexar County, Texas

Trial Court No. 2012-PA-01410

Honorable Charles E. Montemayor, Judge Presiding

ORDER

This is an accelerated appeal of the trial court’s order terminating appellants’ parental 

rights. The notice of appeal was filed on July 25, 2014. Appellants are represented on appeal by 

retained counsel, Mr. Robert Gier. Appellants’ brief was originally due on October 6, 2014. On 

October 3, 2014, Mr. Gier filed a request for an extension of time in which to file appellants’ 

brief, stating he had an active civil trial schedule. We granted an extension until October 20, 

2014. On October 29, 2014, Mr. Gier requested a second extension, citing an active civil trial 

schedule and a child’s respiratory difficulties. Mr. Gier expressly “agree[d] to not request any 

additional extensions.” On October 31, 2014, we granted Mr. Gier an extension until November 

10, 2014 and stated no further extensions of time would be granted.

On November 18, 2014, Mr. Gier filed a third request for an extension, citing the active 

trial schedule, a child’s respiratory difficulties, and the size of the record in this appeal. Again, 

Mr. Gier expressly “agree[d] to not request any additional extensions.” 

Because this is an accelerated appeal of the trial court’s order terminating appellants’ 

parental rights, Rule 6.2 of the Texas Rules of Judicial Administration mandates that this appeal 

be brought to final disposition within 180 days of the date the notice of appeal is filed. TEX. R.

JUD. ADMIN. 6.2. This mandated deadline cannot be re-set or extended by this court. 

We grant Mr. Gier’s request for an extension of time and he is hereby ORDERED to file 

appellants’ brief no later than November 24, 2014. No further extensions of time will be 

considered or granted, and if Mr. Gier fails to file appellants’ brief by November 24, 2014, this 

appeal will be dismissed for want of prosecution.

_________________________________

Sandee Bryan Marion, Justice
IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 19th day of November, 2014.

___________________________________

Keith E. Hottle

Clerk of Court
# **Exhibit 32.1**

 

**CERTIFICATIONOF PRINCIPAL EXECUTIVE OFFICER**

**PURSUANTTO 18 U.S.C. SECTION 1350,**

**AS ADOPTEDPURSUANT TO SECTION 906**

**OF THESARBANES-OXLEY ACT OF 2002**

 

I, Howard R. Levine, Chairman ofthe Board and Chief Executive Officer of Family Dollar Stores, Inc. (the “Company”),do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant toSection 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

•                  the Quarterly Report on Form 10-Q of theCompany for the quarter ended May 28, 2005, as filed with the Securities andExchange Commission (the “Report”), fully complies with the requirements ofSection 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

•                  the information contained in the Reportfairly presents, in all material respects, the financial condition and resultsof operations of the Company.

 

 
| Date: July 1, 2005                                 |   |
|----------------------------------------------------|--------|
|                                               |   |
|                                               |   |
| /s/ Howard R. Levine                               |   |   |
| Howard R. Levine                                   |   |
| Chairman of the Board and Chief  Executive Officer |   |
| (Principal Executive Officer)                      |   |
|                                                    |        |  |

 

A signed original of this writtenstatement required by Section 906 has been provided to Family Dollar Stores,Inc. and will be retained by Family Dollar Stores, Inc. and furnished to theSecurities and Exchange Commission or its staff upon request.

 

----
Converted by EDGARwiz





FIRST AMENDMENT TO PURCHASE AGREEMENT

(Scottsburg Healthcare Center)




This First Amendment to Purchase Agreement (Scottsburg Healthcare Center) is made effective November _, 2008 by and between Vantage Medical, Inc., a Texas corporation, ("Purchaser") and National Assistance Bureau, Inc., an Indiana non-profit corporation ("Seller").




Recitals




A.

The parties entered into a Purchase Agreement (Scottsburg Healthcare Center) dated as of October 9, 2008 (the “Purchase Agreement”, all capitalized terms used herein and not otherwise defined having the meanings ascribed to them in the Purchase Agreement.)




B.

The parties wish to amend the Purchase Agreement as more particularly set forth herein.




Accordingly, in consideration of the terms, conditions and covenants contained in the Purchase Agreement and herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree to amend the Purchase Agreement as follows:




1.

Section 6(D) of the Purchase Agreement is amended by deleting the second sentence in its entirety and substituting the following in lieu thereof:




"Should a Report disclose unlawful environmental conditions which materially adversely affect the condition and operations of the Facility, Purchaser shall so notify Seller by December 14, 2008, and Seller shall be given a reasonable time, not to exceed thirty (30) days in which to correct any such deficiencies or condition."




2.

The Purchase Agreement is unchanged except as specifically set forth herein.




IN WITNESS WHEREOF, each of the parties has caused this First Amendment to Purchase Agreement (Scottsburg Healthcare Center) to be executed on the day first written above.

[Signature page follows]














SIGNATURES




PURCHASER;

SELLER:




Vantage Medical, Inc.

National Assistance Bureau, Inc.




By:  /s/ William F. Smith, President

By:  /s/ William R. Hill, President
<PAGE>


                                                                    EXHIBIT 32.1

    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report on Form 10-Q of Fansteel Inc.,
a Delaware corporation (the "Company"), on Form 10-Q for the quarter ended March
31, 2004, as filed with the Securities and Exchange Commission on the date
hereof (the "Report"), Gary L. Tessitore, as Chairman, President and Chief
Executive Office of the Company and R. Michael McEntee, as Vice President and
Chief Financial Officer of the Company, each hereby certify, pursuant to 18
U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of
2002, that:

     1.  The Report fully complies with the requirements of section 13(a) or
         15(d) of the Securities Exchange Act of 1934; and

     2.  The information contained in the Report fairly presents, in all
         material respects, the financial condition and result of operations of
         the Company.

A signed original of this written statement required by Section 906, or other
document authenticating, acknowledging or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
required by Section 906, has been provided to Fansteel Inc. and will be retained
by Fansteel Inc. and furnished to the Securities and Exchange Commission or its
staff upon request.


Dated: May 14, 2004

                                            /s/ Gary L. Tessitore
                                            ------------------------------------
                                            Gary L. Tessitore
                                            Chairman of the Board, President and
                                            Chief Executive Officer


                                            /s/ R. Michael McEntee
                                            ------------------------------------
                                            R. Michael McEntee
                                            Vice President and
                                            Chief Financial Officer
**Exhibit 32.1**     The following is the certification required pursuant to18 U.S.C. Section 1350, as adopted pursuant toSection 906 of the Sarbanes-Oxley Act of 2002.     In connection with the annual report of CardiogenesisCorporation (the “Company”) onForm 10-K/ A forthe year ended December 31, 2004 as filed with the SEC onthe date hereof (the “Report”), I, Michael J.Quinn, Chief Executive Officer of the Company, certify, pursuantto 18 U.S.C. § 1350, as adopted pursuant to§ 906 of the Sarbanes-Oxley Act of 2002, that:          (1) The Report fully complies with the requirements of    section 13(a) or 15(d) of the Securities Exchange Act of    1934; and           (2) The information contained in the Report fairly    presents, in all material respects, the financial condition and    results of operations of the Company.     /s/ Michael J. Quinn           Michael J. Quinn *Chief Executive Officer*May 2, 2005     The following is the certification required pursuant to18 U.S.C. Section 1350, as adopted pursuant toSection 906 of the Sarbanes-Oxley Act of 2002.     In connection with the annual report of CardiogenesisCorporation (the “Company”) onForm 10-K/ A forthe year ended December 31, 2004 as filed with the SEC onthe date hereof (the “Report”), I, Christine G.Ocampo Chief Financial Officer of the Company, certify, pursuantto 18 U.S.C. § 1350, as adopted pursuant to§ 906 of the Sarbanes-Oxley Act of 2002, that:          (1) The Report fully complies with the requirements of    section 13(a) or 15(d) of the Securities Exchange Act of    1934; and           (2) The information contained in the Report fairly    presents, in all material respects, the financial condition and    results of operations of the Company.     /s/ Christine G. Ocampo           Christine G. Ocampo *Chief Financial Officer*May 2, 2005     The certifications set forth above shall not, except to theextent required by the Sarbanes-Oxley Act of 2002, be deemedfiled by the Company.
Michigan Supreme Court

Lansing, Michigan

Robert P. Young, Jr.,

 Chief Justice

Michael F. Cavanagh

Marilyn Kelly

Stephen J. Markman

Diane M. Hathaway

Mary Beth Kelly

Brian K. Zahra, Justices

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the 

foregoing is a true and complete copy of the order entered at the direction of the Court. 

 _________________________________________ 

 Clerk

March 8, 2011 

p0228 

Order 

 

March 8, 2011 

141789 

PEOPLE OF THE STATE OF MICHIGAN, 

Plaintiff-Appellee, 

v SC: 141789 

 COA: 298806 

Bay CC: 09-010113-FH 

DERRICK JOHN WEDDEL, 

Defendant-Appellant. 

_________________________________________/ 

On order of the Court, the application for leave to appeal the August 6, 2010 order 

of the Court of Appeals is considered, and it is DENIED, because we are not persuaded 

that the question presented should be reviewed by this Court.
_________________________________________ 

 

 

Order Michigan Supreme Court 

Lansing, Michigan 

October 31, 2005 Clifford W. Taylor,

 Chief Justice 

128435 Michael F. Cavanagh 

Elizabeth A. Weaver 

Marilyn Kelly 

Maura D. Corrigan 

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff-Appellee, 

Robert P. Young, Jr. 

Stephen J. Markman,

 Justices 

v SC: 128435 

 COA: 251353 

Calhoun CC: 2002-004919-FC 

JAMES ALFORD WINGFIELD, 

Defendant-Appellant. 

_________________________________________/ 

On order of the Court, the application for leave to appeal the February 15, 2005 

judgment of the Court of Appeals is considered, and it is DENIED, because we are not 

persuaded that the questions presented should be reviewed by this Court. 

t1024 

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the 

foregoing is a true and complete copy of the order entered at the direction of the Court. 

October 31, 2005 

Clerk
[Federal Register Volume 83, Number 111 (Friday, June 8, 2018)]
[Notices]
[Page 26685]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12312]



[[Page 26685]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Agency Information Collection Activities: Proposed Collection; 
Comment Request; Correction

AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department 
of Health and Human Services.

ACTION: Notice, correction.

-----------------------------------------------------------------------

SUMMARY: The Agency for Healthcare Research and Quality published a 
correction document in the Federal Register of May 29, 2018 regarding 
AHRQ Seeking Input on Library of Patient-Centered Outcomes Research 
Resources. This document contained an error in the email address where 
comments should be submitted.

FOR FURTHER INFORMATION CONTACT: Carla Ladner at 301-427-1205 or 
<a href="/cdn-cgi/l/email-protection#f6b7bea4a7a9b09392a9a493919f85829384b6979e8487d89e9e85d8919980"><span class="__cf_email__" data-cfemail="dd9c958f8c829bb8b9828fb8bab4aea9b8af9dbcb5afacf3b5b5aef3bab2ab">[email protected]</span></a>.

Correction

    In the correction to the Federal Register of May 29, 2018, in FR 
Doc 2018-11472, on page 1, line 29, correct the caption under Addresses 
to read: Electronic responses are preferred and should be sent to: 
<a href="/cdn-cgi/l/email-protection#5b0b181409093e28342e29383e281b3a33292a75333328753c342d"><span class="__cf_email__" data-cfemail="1545565a474770667a606776706655747d67643b7d7d663b727a63">[email protected]</span></a>.

    Dated: June 4, 2018.
Carla M. Ladner,
Correspondence Analyst/Federal Register Liaison--AHRQ.
[FR Doc. 2018-12312 Filed 6-7-18; 8:45 am]
 BILLING CODE 4160-90-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
#### George ABRAHMS, Appellant, v. STATE of Florida, Appellee.

No. 69-798.

District Court of Appeal of Florida, Fourth District.

May 26, 1971.

Appeal from Circuit Court, Brevard County; Volie A. Williams, Jr., Judge.

Appeal dismissed.
Venture Stores, Inc.
                 Computation of Earnings (Loss) Per Share

(thousands, except per share data)                             EXHIBIT 11


                                                Fiscal Year Ended          
                                      January 25,  January 27,  January 28,
                                          1997         1996         1995   
Net earnings (loss)                   $ (58,478)   $ (19,855)   $  28,713
Less Preferred dividend                  (2,500)      (2,500)      (2,500)
Net earnings (loss) available to
  common                              $ (60,978)   $ (22,355)   $  26,213 
               
Average outstanding shares               18,025       17,308       17,181 
               
Earnings (loss) per common share      $   (3.38)   $   (1.29)   $    1.53 

PRIMARY:            
               
Net earnings (loss)                   $ (58,478)   $ (19,855)   $  28,713
Less Preferred dividend                  (2,500)      (2,500)      (2,500)
Net earnings (loss) available to
  common                              $ (60,978)   $ (22,355)   $  26,213 
               
Average outstanding shares               18,025       17,308       17,181 
Net effect of dilutive stock
  options - based on the treasury
  method                                    -             25           51 
Average shares for primary 
  earnings per share                     18,025       17,333       17,232 
               
Primary earnings (loss) per common
  share                               $   (3.38)   $   (1.29)   $    1.52 

FULLY DILUTED:           
               
Net earnings (loss)                   $ (58,478)   $ (19,855)   $  28,713
Less Preferred dividend                  (2,500)      (2,500)      (2,500)
Net earnings (loss) available 
  to common                           $ (60,978)   $ (22,355)   $  26,213 
               
Average outstanding shares               18,025       17,308       17,181
Net effect of dilutive stock
  options - based on the treasury
  method                                    -             25           51
Average shares due to conversion 
  of preferred stock                        -            -            -   
Average shares for fully diluted
  earnings per share                     18,025       17,333       17,232 
               
Fully diluted earnings (loss) per
  common share                        $   (3.38)   $   (1.29)   $    1.52
EXHIBIT 11.1

                            BRADLEY PHARMACEUTICALS, INC.
              STATEMENT REGARDING COMPUTATION OF PER SHARE INCOME (LOSS)




                                                  YEAR ENDED
                                               DECEMBER 31, 1995

                                        Primary             Fully Diluted
                                        -------             -------------

          Net Loss                      $(6,921,241)        $(6,921,241)

          Weighted average
          shares outstanding              7,348,975           7,348,975

          Net loss per share                 $(.94)              $(.94)
                                             ======              ======



                                                  YEAR ENDED
                                               DECEMBER 31, 1996

                                        Primary             Fully Dilluted
                                        -------             --------------

          Net Income                    $1,598,507          $1,598,507

          Weighted average
          shares outstanding             7,175,348           7,175,348

          Net loss per share                 $.22                $.22
                                             ====                ====